Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) have been given an average recommendation of “Moderate Buy” by the seven analysts that are presently covering the stock, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating on the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $19.33.

A number of research analysts have recently weighed in on the stock. Mizuho reissued a “neutral” rating and set a $20.00 target price on shares of Sabra Health Care REIT in a research report on Thursday, December 5th. Citizens Jmp raised shares of Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 7th. Truist Financial increased their target price on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “hold” rating in a research report on Tuesday, March 18th. Finally, JMP Securities raised shares of Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 target price for the company in a research report on Tuesday, January 7th.

Sabra Health Care REIT Trading Down 0.4 %

SBRA opened at $17.26 on Monday. The company has a debt-to-equity ratio of 0.88, a current ratio of 4.32 and a quick ratio of 4.16. Sabra Health Care REIT has a fifty-two week low of $13.31 and a fifty-two week high of $20.03. The firm has a market capitalization of $4.11 billion, a PE ratio of 32.57, a P/E/G ratio of 1.97 and a beta of 1.27. The company’s 50-day moving average is $16.79 and its 200 day moving average is $17.68.

Sabra Health Care REIT (NASDAQ:SBRA) last posted its earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.36. The company had revenue of $182.35 million for the quarter, compared to analyst estimates of $178.01 million. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.60%. As a group, research analysts predict that Sabra Health Care REIT will post 1.45 earnings per share for the current fiscal year.

Sabra Health Care REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Friday, February 14th were given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.95%. The ex-dividend date was Friday, February 14th. Sabra Health Care REIT’s payout ratio is 226.42%.

Hedge Funds Weigh In On Sabra Health Care REIT

A number of hedge funds have recently modified their holdings of SBRA. VSM Wealth Advisory LLC bought a new stake in shares of Sabra Health Care REIT during the 4th quarter valued at about $26,000. Quarry LP bought a new stake in shares of Sabra Health Care REIT during the 3rd quarter valued at about $30,000. Assetmark Inc. boosted its stake in shares of Sabra Health Care REIT by 33.4% during the 4th quarter. Assetmark Inc. now owns 2,618 shares of the real estate investment trust’s stock valued at $45,000 after purchasing an additional 656 shares in the last quarter. Wilmington Savings Fund Society FSB bought a new stake in shares of Sabra Health Care REIT during the 3rd quarter valued at about $59,000. Finally, GF Fund Management CO. LTD. bought a new stake in shares of Sabra Health Care REIT during the 4th quarter valued at about $74,000. Hedge funds and other institutional investors own 99.40% of the company’s stock.

About Sabra Health Care REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.